VHL and nonpapillary renal cell carcinoma: However, given the wide spectrum of cellular processes that can be regulated by pVHL, the consequences of VHL-deficiency are beyond the activation of HIF signaling, pointing to the diverse molecular mechanisms that are deregulated in ccRCC, and can potentially serve as therapeutic targets [84].